anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Bionomics · pitchdeck

Bionomics | IPO Presentation Deck | 38 slides

38 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Bionomics | IPO Presentation Deck | 38 slides

Bionomics · 2021-12
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 4 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
100% 1/1 slides · 2 hits 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

38
every slide · same image gating as the playbook
01
Slide 1
Includes stock tickers (ASX: BNO, OTCQB: BNOEF) and date (December 2021).front_matter
Open slide detail
02
other
Open slide detail
03
Includes specific financial details like gross proceeds, use of proceeds, and bookrunners.other
Open slide detail
04
The slide uses a vertical timeline-like structure to present key company highlights.summarize
Open slide detail
05
The slide uses a grid layout to present leadership profiles and a list for the board of directors, supplemented by a logo grid representing past/current experieother
Open slide detailBeat · Team
06
The slide uses a Gantt-style layout to show clinical trial progress for BNC210 and collaborative programs.plan_implementation
Open slide detail
07
The slide uses a biological process diagram to illustrate how allosteric modulation works and a conceptual graph to show how the drug candidates normalize hyperpresent_solution
Open slide detail
08
The slide uses a biological process diagram to contrast normal brain function with anxiety/PTSD states and the corrective effect of the drug.present_solution
Open slide detail
09
Slide 9 of the deck.transition
Open slide detail
10
Uses a funnel-like visual to represent market segmentation/prevalence.size_opportunity
Open slide detailBeat · Market Size
11
The study uses a CCK-4-induced panic attack model to measure efficacy.show_traction
Open slide detail
12
Includes fMRI and behavioral task (JORT) data.show_traction
Open slide detail
13
The slide uses a hub-and-spoke diagram to highlight BNC210's value proposition and a comparison table to frame the competitive landscape.compare_peers
Open slide detail
14
Includes a pharmacokinetic chart showing concentration vs time for different doses.argue_timing
Open slide detailLoop · Why Now
15
Includes clinical trial design flow chart and regulatory milestones.plan_implementation
Open slide detail
16
transition
Open slide detail
17
Uses a funnel-like visual to represent the narrowing of the patient population from total prevalence to those inadequately treated.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
18
The slide uses a combination of a line chart for animal model data and a bar chart for human translational data to support the therapeutic thesis.show_traction
Open slide detailLoop · Cost Of Inaction
19
The slide uses a circular diagram to show BNC210's core strengths and a comparison table to contrast it with current SSRI/SNRI treatments.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
20
The slide uses a process flow diagram to show the evolution of the drug program from initial trial results to the ongoing ATTUNE study.plan_implementation
Open slide detailLoop · Cost Of Inaction
21
Includes a pharmacometric exposure-response curve and a pharmacokinetic time-concentration profile.show_traction
Open slide detail
22
The slide uses a timeline-based visual to explain the clinical trial structure.plan_implementation
Open slide detail
23
transition
Open slide detail
24
Includes three bar charts showing BNC375 efficacy in animal models.show_traction
Open slide detail
25
Uses a newspaper graphic to frame the MOU announcement as a significant news event.show_traction
Open slide detail
26
The slide features a stylized illustration of neurons, reinforcing the CNS theme.transition
Open slide detail
27
The chart shows reversal of PCP-induced cognitive deficits in mice, with percentages indicating the degree of reversal compared to vehicle/PCP controls.present_solution
Open slide detail
28
Uses a process flow for the genetic rationale and a box-based structure for the R&D status.present_solution
Open slide detail
29
transition
Open slide detail
30
Figures as of September 30, 2021.analyze_data
Open slide detail
31
The slide uses a vertical timeline-like structure to list key strategic pillars.summarize
Open slide detail
32
appendix
Open slide detail
33
The table provides a comprehensive overview of clinical development progress across multiple phases and indications.analyze_data
Open slide detail
34
The slide uses a structured table-like layout to present clinical trial parameters.present_framework
Open slide detail
35
The slide uses a mix of bullet points and a callout box for the conclusion/explanation of the primary endpoint failure.summarize
Open slide detail
36
The slide uses a combination of a line chart for data and a process flow diagram to explain the mechanism of action.present_solution
Open slide detail
37
transition
Open slide detail
38
Details the financial milestones (A$118M) and strategic partnership for CAR-T therapy development.show_traction
Open slide detail